Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
CDC’s website is being modified to comply with President Trump’s Executive Orders.
Volume 12, Number 2—February 2006
Letter

Congenital Visceral Leishmaniasis

Catharina C. Boehme*Comments to Author , Ulrike Hain*, Astrid Novosel*, Susanna Eichenlaub*, Erna Fleischmann*, and Thomas Löscher*
Author affiliations: *University of Munich, Munich, Germany

Main Article

Figure

A) Immunoblot of the patient (strip no. 21) and the patient's mother (strip no. 22) showing specific antibodies against 14- and 16-kDa proteins of Leishmania infantum. B) restriction fragment length polymorphism patterns after HaeIII digestion of the ribosomal internal transcribed spacer 1 polymerase chain reaction products. P, patient; Li, L. infantum; Lm, L. major; Lt, L. tropica; M, 100-bp ladder.

Figure. A) Immunoblot of the patient (strip no. 21) and the patient's mother (strip no. 22) showing specific antibodies against 14- and 16-kDa proteins of Leishmania infantum. B) restriction fragment length polymorphism patterns after HaeIII digestion of the ribosomal internal transcribed spacer 1 polymerase chain reaction products. P, patient; Li, L. infantum; Lm, L. major; Lt, L. tropica; M, 100-bp ladder.

Main Article

Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external